Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cognitive Dysfunction × Radiosurgery × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 99 Carcinoma, Non-Small-Cell Lung 91 Prostatic Neoplasms 89 Neoplasm Metastasis 70 Lung Neoplasms 56 Pancreatic Neoplasms 55 Carcinoma, Hepatocellular 52 Breast Neoplasms 41 Melanoma 34 Carcinoma, Renal Cell 27 Neoplasms 25 Glioblastoma 17 Squamous Cell Carcinoma of Head and Neck 16 Colorectal Neoplasms 16 Liver Neoplasms 15 Small Cell Lung Carcinoma 12 Sarcoma 10 Kidney Neoplasms 10 Head and Neck Neoplasms 10 Glioma 10 Recurrence 8 Urinary Bladder Neoplasms 6 Radiation Injuries 6 Neuroma, Acoustic 6 Adenocarcinoma 6 Uveal Melanoma 5 Uterine Cervical Neoplasms 5 Ovarian Neoplasms 5 Meningioma 5 Spinal Cord Neoplasms 4

Interventions

Exercise 6 Transcranial Direct Current Stimulation 4 Neuropsychological Tests 4 Memantine 3 Walking 2 Standard of Care 2 Patient Reported Outcome Measures 2 Methods 2 Electroencephalography 2 Donepezil 2 Cognitive Behavioral Therapy 2 mazdutide 1 lime 1 enzalutamide 1 beta Carotene 1 acetaminophen, aspirin, caffeine drug combination 1 Vitamin E 1 Vitamin D 1 Ultraviolet Therapy 1 Time 1 Tai Ji 1 Tablets 1 Surveys and Questionnaires 1 Sugars 1 Sodium Chloride 1 Sirolimus 1 Riluzole 1 Rehabilitation, Vocational 1 Referral and Consultation 1 Ramipril 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06466720 2024-12-11

CoDeB-Rad

University of Nottingham

Brain Neoplasms, Meningioma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡